Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"
Br J Cancer
.
2021 Feb;124(3):679-680.
doi: 10.1038/s41416-020-01133-8.
Epub 2020 Nov 3.
Authors
Christopher M Jones
1
2
3
,
Ganesh Radhakrishna
4
,
Katharine Aitken
5
6
,
John Bridgewater
7
,
Pippa Corrie
8
,
Martin Eatock
9
,
Rebecca Goody
2
3
,
Paula Ghaneh
10
,
James Good
11
,
Derek Grose
12
,
Daniel Holyoake
13
,
Arabella Hunt
5
6
,
Nigel B Jamieson
14
,
Daniel H Palmer
15
16
,
Zahir Soonawalla
17
,
Juan W Valle
4
18
,
Maria A Hawkins
19
,
Somnath Mukherjee
20
Affiliations
1
Faculty of Biological Sciences, University of Leeds, Leeds, UK.
2
Radiotherapy Research Group, Faculty of Medicsine & Health, University of Leeds, Leeds, UK.
3
Leeds Cancer Centre, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
4
The Christie NHS Foundation Trust, Manchester, UK.
5
The Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust, London, UK.
6
The Institute of Cancer Research, London, UK.
7
University College London Cancer Institute, London, UK.
8
Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
9
The Northern Ireland Cancer Centre, Belfast, UK.
10
The Royal Liverpool University Hospital, Liverpool, UK.
11
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
12
Beatson West of Scotland Cancer Centre, Glasgow, UK.
13
Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
14
Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK.
15
The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
16
Liverpool Experimental Cancer Medicine Centre, University of Liverpool, Liverpool, UK.
17
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
18
Division of Cancer Sciences, University of Manchester, Manchester, UK.
19
Department of Medical Physics & Biomedical Engineering, University College London, London, UK.
20
CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford, UK. somnath.mukherjee@oncology.ox.ac.uk.
PMID:
33139799
PMCID:
PMC7851158
DOI:
10.1038/s41416-020-01133-8
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Consensus
Humans
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / epidemiology
Pandemics
SARS-CoV-2
United Kingdom / epidemiology
Grants and funding
18787/CRUK_/Cancer Research UK/United Kingdom
11883/CRUK_/Cancer Research UK/United Kingdom
16186/CRUK_/Cancer Research UK/United Kingdom
16812/CRUK_/Cancer Research UK/United Kingdom
17680/CRUK_/Cancer Research UK/United Kingdom
08/29/02/DH_/Department of Health/United Kingdom
15957/CRUK_/Cancer Research UK/United Kingdom
8968/CRUK_/Cancer Research UK/United Kingdom